|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 | |||
| C07K 14/475 | |||
| A01N 43/90 |
| (11) | Number of the document | 3035964 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14837218.8 |
| Date of filing the European patent application | 2014-08-15 | |
| (97) | Date of publication of the European application | 2016-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/051171 |
| Date | 2014-08-15 |
| (87) | Number | WO 2015/026634 |
| Date | 2015-02-26 |
| (30) | Number | Date | Country code |
| 201361867760 P | 2013-08-20 | US |
| (72) |
STRACK, Peter Richard, US
BOOHER, Robert, US
SRIRAM, Venkataraman, US
PHILLIPS, Joseph, H., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB |
| TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB |